DOJ Investigates $250 Million in U.S. Sales of Counterfeit Drugs Using Fake DSCSA Pedigrees
Policy Prescription
APRIL 1, 2022
What goes unstated is how much of the $78 million in drug products were legitimate and safe drugs, tagged as “unapproved” or “misbranded,” versus counterfeit drugs. Pharmacy Counterfeit Drug Breach Dwarfs CanadaDrugs Case. In 2018, CanadaDrugs, Ltd.
Let's personalize your content